Family Medicine Doctors in Bozeman, MT Accepting Medicare

49 Family Medicine doctors found. Showing 41 - 49

Leah Marie Anderson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 316 E Babcock St, Bozeman, MT 59715 Phone: 406-585-0022    Fax: 406-585-0032

Dr. Claire Anne Caitlin Crane, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 935 Highland Blvd Ste 2200, Bozeman, MT 59715 Phone: 406-414-5700

Melissa Saab Vance, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 935 Highland Blvd Ste 2200, Bozeman, MT 59715 Phone: 406-414-5700

Dr. Ross A Kringlie, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1006 W Main St, Bozeman, MT 59715 Phone: 406-586-8711    Fax: 406-587-2602

Logen Ross Nunberg, NP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 105 E Oak St Ste 1e, Bozeman, MT 59715 Phone: 406-404-1350

Dr. Marjorieb B Fowlkes, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Student Health Service, Montana State University, Bozeman, MT 59715 Phone: 406-994-2311

Royce G Pyette, M.D. Family Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 1450 Ellis St, Suite 201, Bozeman, MT 59715 Phone: 406-587-0122    Fax: 406-587-5548

Colette Andrea Gomez-kirchhoff, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 935 Highland Blvd, Suite 2210, Bozeman, MT 59715 Phone: 406-587-3133    Fax: 406-586-9671

Dr. Christine L Mitchell, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 931 Highland Blvd, Suite 3360, Bozeman, MT 59715 Phone: 406-587-4242    Fax: 406-587-3507

News Archive

Researchers are unraveling the mysteries of amyloid beta peptides in Alzheimer's disease

Alzheimer's disease has long been marked by progress - but not the kind of progress the medical community seeks. It is the most common form of dementia among older Americans, and its risk increases with increasing age; for those living with the disease, its ravages get worse over time; and as we move into the 21st century, it will place a greater and greater burden on society.

Biological activity-based modeling offers a new approach for drug discovery

Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases.

Premier international conference to highlight understanding of cancer disparities

This year, the American Association for Cancer Research will host its third conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved at the Loews Miami Beach Hotel in Miami, Fla.

Arno Therapeutics announces dosing of first patient in Phase II clinical study of AR-67

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.

Study characterizes early chains and patterns of COVID-19 transmission in France

By using data from epidemiological investigations and contact-tracing efforts during the initial phase of the coronavirus disease (COVID-19) epidemic in France, researchers were able to appraise secondary clinical attack rates and factors associated with the risk of a contact becoming a case. Their findings are currently available in a medRxiv preprint paper.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3(current)